BARBARO, MARIA RAFFAELLA
 Distribuzione geografica
Continente #
NA - Nord America 3.967
AS - Asia 3.529
EU - Europa 3.199
AF - Africa 302
Continente sconosciuto - Info sul continente non disponibili 205
SA - Sud America 199
OC - Oceania 20
Totale 11.421
Nazione #
US - Stati Uniti d'America 3.861
IT - Italia 1.667
SG - Singapore 943
CN - Cina 858
VN - Vietnam 785
GB - Regno Unito 332
HK - Hong Kong 328
DE - Germania 243
SE - Svezia 206
IN - India 160
BR - Brasile 144
FR - Francia 143
NL - Olanda 126
RU - Federazione Russa 106
KR - Corea 105
BD - Bangladesh 97
IE - Irlanda 78
TG - Togo 74
CI - Costa d'Avorio 73
FI - Finlandia 60
JP - Giappone 60
ZA - Sudafrica 59
CA - Canada 54
CH - Svizzera 38
BE - Belgio 28
CD - Congo 27
NG - Nigeria 26
EE - Estonia 24
ID - Indonesia 24
PH - Filippine 24
UA - Ucraina 24
AT - Austria 23
AR - Argentina 22
JO - Giordania 21
SC - Seychelles 21
TH - Thailandia 20
BG - Bulgaria 18
ES - Italia 18
TR - Turchia 17
AU - Australia 16
EC - Ecuador 14
MX - Messico 14
TW - Taiwan 14
IR - Iran 13
PL - Polonia 11
AL - Albania 10
PT - Portogallo 10
CO - Colombia 8
IQ - Iraq 7
PK - Pakistan 7
EG - Egitto 6
JM - Giamaica 6
MY - Malesia 6
CZ - Repubblica Ceca 5
HN - Honduras 5
HR - Croazia 5
NI - Nicaragua 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
CL - Cile 4
DK - Danimarca 4
KZ - Kazakistan 4
LT - Lituania 4
MA - Marocco 4
NP - Nepal 4
NZ - Nuova Zelanda 4
SM - San Marino 4
TT - Trinidad e Tobago 4
CR - Costa Rica 3
KE - Kenya 3
KG - Kirghizistan 3
LV - Lettonia 3
PY - Paraguay 3
SA - Arabia Saudita 3
YE - Yemen 3
AG - Antigua e Barbuda 2
BB - Barbados 2
BY - Bielorussia 2
GD - Grenada 2
GR - Grecia 2
IL - Israele 2
OM - Oman 2
RO - Romania 2
SV - El Salvador 2
TN - Tunisia 2
UY - Uruguay 2
AO - Angola 1
BH - Bahrain 1
BO - Bolivia 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
BS - Bahamas 1
BZ - Belize 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GH - Ghana 1
GP - Guadalupe 1
Totale 11.204
Città #
Singapore 689
Ashburn 376
Hong Kong 296
Bologna 292
Fairfield 249
Southend 241
San Jose 233
Hefei 208
Ho Chi Minh City 204
Hanoi 181
Milan 165
Santa Clara 156
Chandler 149
Woodbridge 126
Houston 115
Seattle 114
Wilmington 112
Rome 104
Los Angeles 102
Beijing 96
Seoul 96
Council Bluffs 92
Cambridge 91
Boardman 90
New York 84
Dublin 76
Brescia 74
Lomé 74
Abidjan 73
Princeton 70
Ann Arbor 69
Frankfurt am Main 60
Dallas 56
Florence 55
Dong Ket 54
Lauterbourg 50
Tokyo 49
Helsinki 38
Nanjing 36
Naples 36
Orem 36
Munich 35
Da Nang 30
Padova 30
Johannesburg 29
Haiphong 28
Parma 27
Lubumbashi 26
Turin 26
Westminster 26
Buffalo 25
Berlin 24
Amsterdam 23
Bengaluru 23
Denver 23
Phoenix 23
Redondo Beach 23
São Paulo 23
Abeokuta 22
Bern 21
London 21
Amman 20
Atlanta 20
San Diego 20
Chicago 19
San Francisco 19
Shanghai 19
Montreal 18
Changsha 17
Rimini 17
Brussels 16
Catania 16
Nuremberg 16
Piscataway 16
Lappeenranta 15
Pisa 15
Sofia 15
Guangzhou 14
Hyderabad 14
Jakarta 14
Redmond 14
Reggio Emilia 13
Toronto 13
Vienna 13
Beerse 12
Falls Church 12
Padua 12
Saint Petersburg 12
Modena 11
Secaucus 11
Ardabil 10
Jinan 10
Nanchang 10
Pomigliano d'Arco 10
Poplar 10
The Dalles 10
Thái Nguyên 10
Verona 10
Brooklyn 9
Des Moines 9
Totale 6.616
Nome #
Randomised clinical trial: the analgesic properties of dietary supplementation with palmitoylethanolamide and polydatin in irritable bowel syndrome 541
METODO E KIT PER LA DIAGNOSI DELLA SENSIBILITA’ AL GLUTINE NON ASSOCIATA ALLA CELIACHIA 433
Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study 363
5-oxoETE triggers nociception in constipation-predominant irritable bowel syndrome through MAS-related G protein–coupled receptor D 339
Management of Irritable Bowel Syndrome With Diarrhea 328
Escherichia coli Nissle 1917 restores epithelial permeability alterations induced by irritable bowel syndrome mediators 315
Collinsella aerofaciens as a predictive marker of response to probiotic treatment in non-constipated irritable bowel syndrome 279
Lactiplantibacillus plantarum (CECT7484 and CECT7485) and Pedioccoccus acidilactici (CECT7483) enhance actin cytoskeleton and CYP1A1 expression restoring epithelial permeability alterations induced by irritable bowel syndrome mediators 246
Serum zonulin and its diagnostic performance in non-coeliac gluten sensitivity 242
Nerve fiber outgrowth is increased in the intestinal mucosa of patients with irritable bowel syndrome 241
Pathophysiology of Diverticular Disease: From Diverticula Formation to Symptom Generation 237
Advancements in drug development for diarrhea-predominant irritable bowel syndrome 237
New insights into irritable bowel syndrome pathophysiological mechanisms: contribution of epigenetics 228
Inflammatory and Microbiota-Related Regulation of the Intestinal Epithelial Barrier 225
Effect of Lactobacillus paracasei CNCM I-1572 on symptoms, gut microbiota, short chain fatty acids, and immune activation in patients with irritable bowel syndrome: A pilot randomized clinical trial 224
Gut microbiota, metabolome and immune signatures in patients with uncomplicated diverticular disease 209
The role of microbiota and its modulation in colonic diverticular disease 203
Colonic immune cells in irritable bowel syndrome: A systematic review and meta-analysis 203
Molecular Mechanisms Underlying Loss of Vascular and Epithelial Integrity in Irritable Bowel Syndrome 202
Neuroprotection of microglial conditioned medium on 6-hydroxydopamine-induced neuronal death: role of transforming growth factor beta2 202
Diagnostic challenges of symptomatic uncomplicated diverticular disease 197
Neuroimmune interactions at different intestinal sites are related to abdominal pain symptoms in children with IBS 195
Elucidating the gut microbiome of ulcerative colitis: bifidobacteria as novel microbial biomarkers 194
Non-celiac gluten sensitivity in the context of functional gastrointestinal disorders 190
Post COVID-19 irritable bowel syndrome 186
Consumption of 2 Green Kiwifruits Daily Improves Constipation and Abdominal Comfort - Results of an International Multicenter Randomized Controlled Trial 185
Interferon-γ is increased in the gut of patients with irritable bowel syndrome and modulates serotonin metabolism 184
Fecal Clostridiales distribution and short-chain fatty acids reflect bowel habits in irritable bowel syndrome 183
null 179
The Role of Microbiota in Upper Gastrointestinal Cancers 171
Pathophysiology and Clinical Management of Bile Acid Diarrhea 170
Nerve fiber overgrowth in patients with symptomatic diverticular disease 170
Cytochromes b561: ascorbate-mediated trans-membrane electron transport 168
Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome. 162
Supernatants of irritable bowel syndrome mucosal biopsies impair human colonic smooth muscle contractility 161
Microbiota modulation in disorders of gut-brain interaction 160
Current and Novel Therapies for Eosinophilic Gastrointestinal Diseases 157
Chronic constipation: from pathophysiology to management 156
Meta-analysis: Post-COVID-19 functional dyspepsia and irritable bowel syndrome 153
Treatment of diverticular disease with aminosalicylates: The evidence 145
Corrigendum: Inflammatory and Microbiota-Related Regulation of the Intestinal Epithelial Barrier (Front. Nutr., (2021), 8, (718356), 10.3389/fnut.2021.718356) 145
Implications of SARS-CoV-2 infection for neurogastroenterology 143
Fecal short-chain fatty acids in non-constipated irritable bowel syndrome: a potential clinically relevant stratification factor based on catabotyping analysis 138
Recent advances in understanding non-celiac gluten sensitivity 137
µ-opioid receptor, β-endorphin, and cannabinoid receptor-2 are increased in the colonic mucosa of irritable bowel syndrome patients. 135
Protease-activated receptor 1 is implicated in irritable bowel syndrome mediators-induced signaling to thoracic human sensory neurons 128
Antibiotic use during gastrointestinal infections increases the risk of developing irritable bowel syndrome: a Systematic Review and Meta-Analysis 118
Gut microbiota signatures and modulation in irritable bowel syndrome 117
Pre- and probiotic overview 117
AIR12, a b-type cytochrome of the plasma membrane of Arabidopsis thaliana is a negative regulator of resistance against Botrytis cinerea 117
null 101
Impact of the Trophic Effects of the Secretome from a Multistrain Probiotic Preparation on the Intestinal Epithelia 98
Long-Term Impact of COVID-19 on Disorders of Gut–Brain Interaction: Incidence, Symptom Burden, and Psychological Comorbidities 95
Role of inflammation in pediatric irritable bowel syndrome 93
Digestive symptoms in daily life of chronic adrenal insufficiency patients are similar to irritable bowel syndrome symptoms 92
A Probiotic Mixture of Lactobacillus rhamnosus LR 32, Bifidobacterium lactis BL 04, and Bifidobacterium longum BB 536 Counteracts the Increase in Permeability Induced by the Mucosal Mediators of Irritable Bowel Syndrome by Acting on Zonula Occludens 1 92
Italian nationwide survey of pharmacologic treatments in diverticular disease: Results from the REMAD registry 88
Letter: Post-COVID-19 disorders of gut–brain interaction (DGBI)—just post-infectious or a multifaceted entity? Authors' reply 86
Functional Foods and Nutraceuticals in Irritable Bowel Syndrome 86
null 81
Multistrain Probiotics Plus Vitamin D Improve Gut Barrier Function and Gut Microbiota Composition in Irritable Bowel Syndrome Without Constipation: Results from a Double-Blind, Randomized, Placebo-Controlled Trial 70
Letter: Post-COVID-19 functional dyspepsia and irritable bowel syndrome—Authors' reply 68
Psychological and Clinical Factors Mediate Post-COVID-19 Irritable Bowel Syndrome 59
Therapeutic Role of Probiotics for the Treatment of Dyspepsia: A Review of the Literature 54
Totale 11.421
Categoria #
all - tutte 30.496
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.496


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022812 0 44 17 36 75 47 44 44 53 24 325 103
2022/20231.053 79 216 75 83 79 84 34 91 157 24 67 64
2023/2024594 21 60 40 57 70 69 23 30 30 86 64 44
2024/20252.109 116 266 190 203 275 104 148 127 75 140 158 307
2025/20264.488 310 381 332 338 361 219 637 190 839 307 237 337
2026/2027739 404 335 0 0 0 0 0 0 0 0 0 0
Totale 11.421